| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KPIL
|
1,400.90 | 239.2B | 5.26 | 3.08 | 2.91 | 14.1% | 14.6% | 77 | 56 | 2,740.85 | +71.7% | 78 | 0.46 |
|
IRB
|
19.36 | 233.8B | 6.13 | 1.10 | 3.94 | 3.2% | 11.6% | 73 | 38 | 37.70 | +68.2% | 65 | 0.94 |
|
ACMESOLAR
|
401.95 | 283.6B | 11.75 | 4.81 | 4.14 | 5.9% | 12.1% | 53 | 32 | 438.11 | +6.5% | 65 | 3.37 |
|
JSWINFRA
|
340.00 | 714.0B | 12.02 | 6.52 | 7.14 | 9.9% | 15.0% | 48 | 30 | 283.26 | -12.0% | 75 | 0.63 |
|
RVNL
|
210.00 | 437.9B | 12.17 | 4.44 | 13.32 | 4.5% | 14.9% | 46 | 24 | 168.15 | -14.3% | 65 | 0.49 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.